Akebia Therapeutics, Inc.
AKBA
$1.18
$0.032.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 162.64M | 184.84M | 166.44M | 137.31M | 113.37M |
| Total Receivables | 62.54M | 47.03M | 66.22M | 72.81M | 61.54M |
| Inventory | 13.00M | 15.61M | 18.64M | 16.71M | 19.73M |
| Prepaid Expenses | -- | -- | -- | -- | 1.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.31M | 5.47M | 7.03M | 7.83M | 7.92M |
| Total Current Assets | 243.48M | 252.96M | 258.34M | 234.66M | 203.78M |
|
|
|||||
| Total Current Assets | 243.48M | 252.96M | 258.34M | 234.66M | 203.78M |
| Net Property, Plant & Equipment | 3.42M | 4.89M | 6.31M | 7.70M | 9.02M |
| Long-term Investments | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M |
| Goodwill | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.57M | 59.68M | 40.46M | 44.19M | 38.34M |
| Total Assets | 362.52M | 376.57M | 364.15M | 345.60M | 310.19M |
|
|
|||||
| Total Accounts Payable | 8.39M | 21.19M | 10.09M | 11.55M | 12.66M |
| Total Accrued Expenses | 93.54M | 92.13M | 76.19M | 59.14M | 39.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.47M | 22.57M | 20.07M | 17.80M | 13.55M |
| Total Finance Division Other Current Liabilities | 32.50M | 27.06M | 27.04M | 30.22M | 25.24M |
| Total Other Current Liabilities | 32.50M | 27.06M | 27.04M | 30.22M | 25.24M |
| Total Current Liabilities | 173.88M | 162.94M | 133.38M | 118.72M | 91.23M |
|
|
|||||
| Total Current Liabilities | 173.88M | 162.94M | 133.38M | 118.72M | 91.23M |
| Long-Term Debt | 158.06M | 176.21M | 178.94M | 177.43M | 179.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 671.00K | 2.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.21M | 4.80M | 10.24M | 19.55M | 12.33M |
| Total Liabilities | 335.15M | 343.96M | 322.56M | 316.37M | 285.60M |
|
|
|||||
| Common Stock & APIC | 1.72B | 1.72B | 1.71B | 1.70B | 1.70B |
| Retained Earnings | -1.69B | -1.68B | -1.67B | -1.67B | -1.67B |
| Treasury Stock & Other | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Total Common Equity | 27.38M | 32.61M | 41.59M | 29.22M | 24.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.38M | 32.61M | 41.59M | 29.22M | 24.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.38M | 32.61M | 41.59M | 29.22M | 24.58M |
|
|
|||||